Komori
Ensuiko Sugar Refining (2112) · InitiativeLower revenue due to continued advertising placements and sluggish sales of some productsLatest Earnings (2026-08-07): "Advanced"

Expansion of sales in the oligosaccharide business

First written in FY2017-Q1. 12 of 36 entries say "Advanced", first in FY2019-Q2. Latest entry: 2026-08-07.

36entries
11years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017-Q1 – FY2019-Q1OtherFY2023-Q1 – FY2025-H12016: 220162017: 320172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 120242025: 220252026: 42026
Same theme, other companies
Expansion of oligosaccharide product salesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. 2026-08-07AdvancedEarnings

    「オリゴ糖製品は、『オリゴのおかげ』のヘビーユーザー向け大容量品の売上が伸長したことをはじめ、家庭用商品が好調に推移した結果、売上高は前年同四半期を上回りました。」

    ヘビーユーザー向け大容量品と家庭用商品の販売好調により、オリゴ糖部門の売上高が前年同期を上回った。
  2. FY2026Lower revenue due to continued advertising placements and sluggish sales of some productsAnnual report

    「We continued to use beauty specialist IKKO (IKKO氏) and rakugo performer Hayashiya Tsuruko (林家つる子) as the main characters and conducted advertising campaigns to raise awareness of the “Oligo no Okage = gut health” association. Although products for core users, such as the large-size type, remained firm, net sales were below the same period of the previous year because sales of some household and commercial-use products remained weak.」

    Advertising engagements and efforts to establish the gut health image continued, and products for core users remained firm, while segment net sales were below the previous year due to weak performance by some household and commercial-use products.
  3. FY2026-H1Expanded advertising engagements and stronger core-user demand, but lower net salesAnnual report

    「In the oligosaccharide segment, we engaged beauty specialist IKKO (IKKO氏) and rakugo performer Hayashiya Tsuruko (林家つる子) as the main characters in advertising campaigns to establish the association “Oligo no Okage = gut health.” While demand for products for core users, such as the large-size type, continued to rise steadily, some household and commercial-use products performed weakly, and net sales were below the previous interim consolidated accounting period.」

    In addition to IKKO (IKKO氏), Hayashiya Tsuruko (林家つる子) was engaged for advertising aimed at establishing the “gut health” image. While demand for products for core users, such as the large-size type, increased, net sales were below the previous interim period due to weak performance by some products.
  4. FY2025AdvancedAnnual report

    「To meet the needs of light users whose numbers had grown with the expansion of the oligosaccharide market and to pursue further growth in the oligosaccharide business, we launched SUGAR CANE OLIGO in autumn of the previous year.」

    In addition to the existing Oligo no Okage series, SUGAR CANE OLIGO was launched for light users, broadening the customer base and product lineup.
  5. FY2025-H1Strong sales of products for core users as the boom subsided, broadly flat net salesAnnual report

    「In the oligosaccharide segment, as the oligosaccharide boom began to settle, sales of the regular type in the Oligo no Okage series remained weak. However, sales of products for core users, including the large-size and premium types with higher oligosaccharide content, remained strong, and net sales were broadly level with the previous year.」

    While the regular type was weak as the oligosaccharide boom subsided, sales of products for core users, including the large-size and premium types, were strong, leaving net sales broadly level with the previous year.
  6. FY2024-Q2Stronger promotions using IKKO, recovery in demand, but lower net salesAnnual report

    「In the oligosaccharide segment, the Oligo no Okage series had performed strongly through the previous fiscal year, benefiting from heightened health awareness and special demand from television coverage, but demand paused and performance was weak in the current fiscal year. From late August, IKKO (IKKO氏), a beauty specialist, was engaged as the main character for Oligo no Okage, and active promotional activities were conducted through TV commercials, newspaper advertising, and social media. Demand began to recover, but net sales were below the same quarter of the previous year.」

    After a weak period as demand paused, the business began to recover through promotions using IKKO (IKKO氏), TV commercials, newspaper advertising, and social media, but net sales were below the same period of the previous year.
  7. FY2024-Q1Lower net sales as demand pausedAnnual report

    「In the oligosaccharide segment, the Oligo no Okage series had performed strongly through the previous fiscal year, benefiting from heightened health awareness and special demand generated by television coverage. In the current fiscal year, however, demand paused, and net sales were below the same quarter of the previous year.」

    Demand paused after the strong performance driven by health awareness and special demand from television coverage, and net sales for the oligosaccharide segment were below the same quarter of the previous year.
  8. FY2023Expanded sales of the large-size type amid the reversal of special demandAnnual report

    「Sales of the large-size type in the Oligo no Okage series increased, but net sales were below the same period of the previous year because of the reversal of special demand generated after oligosaccharides were featured on a popular television program in the previous fiscal year.」

    Although the reversal of special demand resulted in lower net sales, sales growth in the large-size type and strengthened promotional activities were evident.
  9. FY2023-Q3Resilient demand amid the reversal of special demand, broadly unchanged year on yearAnnual report

    「In the oligosaccharide segment, although there was a reversal of special demand after oligosaccharides were featured on a popular television program in the previous fiscal year, sales of the large-size type continued to grow on resilient demand for oligosaccharides driven by rising consumer needs for intestinal health. Net sales were maintained at approximately the same level as the same quarter of the previous year as promotional activities were strengthened.」

    While there was a reversal of the special demand generated by the previous year’s television program, growth in sales of the large-size type and strengthened promotional activities kept net sales approximately level with the same quarter of the previous year.
  10. FY2023-Q2Declining net sales due to the reversal of special demandAnnual report

    「In the oligosaccharide segment, we focused on expanding sales of the Oligo no Okage series, a food for specified health uses, as its benefits for intestinal health and their connection with improved immunity attracted attention during the prolonged COVID-19 pandemic. However, net sales were below the same quarter of the previous year because of the significant impact of the reversal of special demand that arose after oligosaccharides were featured on a popular television program in the same quarter of the previous year.」

    Sales expansion of the Oligo no Okage series continued, but net sales were below the same quarter of the previous year due to the reversal of special demand triggered by its appearance on a popular television program in the same quarter of the previous year.
  11. FY2023-Q1RestatedAnnual report

    「In the oligosaccharide segment, we focused on expanding sales of our Oligo no Okage series, a food for specified health uses, against the tailwind of the “gut health” boom, which attracted attention as a way to strengthen immunity during the prolonged COVID-19 pandemic. As a result, sales of the large-size type remained strong in addition to the regular product, and net sales exceeded the same quarter of the previous year.」

    Against the backdrop of growing interest in gut health, sales expansion of the regular and large-size products continued, with net sales exceeding the same period of the previous year.
  12. FY2022AdvancedAnnual report

    「Growth in the large-size type was particularly strong, and sales volume reached a record high.」

    Sales volume for the Oligo no Okage series reached a record high. The company has set out plans to strengthen the business, including through wider use of media, overseas expansion, and increased production.
  13. FY2022-Q3AdvancedAnnual report

    「In the oligosaccharide segment, sales of the Oligo no Okage series remained strong amid heightened health awareness during the COVID-19 pandemic, with particularly significant growth in the large-size type, and sales volume exceeded the previous year. However, net sales were below the same quarter of the previous year because the Accounting Standard for Revenue Recognition and other standards were adopted from the beginning of the first quarter of the current fiscal year.」

    Sales volume for the series exceeded the previous year, driven by particularly strong growth in the large-size type. However, net sales were below the same quarter of the previous year due to adoption of the accounting standard for revenue recognition.
  14. FY2022-Q2Strong sales, lower net sales due to adoption of accounting standardsAnnual report

    「In the oligosaccharide segment, we proposed Oligo no Okage, a food for specified health uses, through various advertising campaigns and other measures to expand sales and actively grow the business. In addition, continued interest in health, including the feature on oligosaccharides in a popular television program, made a significant contribution to sales growth. As a result, sales of the product series as a whole remained strong, and sales volume exceeded the previous year. However, net sales declined and were below the same quarter of the previous year because the Accounting Standard for Revenue Recognition and other standards were adopted from the beginning of the first quarter of the current fiscal year.」

    While sales volume across the product series exceeded the previous year due to sales expansion through various advertising campaigns and heightened health awareness, net sales were below the same quarter of the previous year due to adoption of the accounting standard for revenue recognition.
  15. FY2022-Q1Higher sales volume, lower net sales due to adoption of accounting standardsAnnual report

    「In the oligosaccharide segment, magazine advertising and other measures were rolled out to expand sales of the Oligo no Okage series, and we actively worked to expand the business. Sales of the large-size and Double Support types were particularly strong, and sales volume exceeded the previous year. However, net sales declined and were below the same quarter of the previous year because the Accounting Standard for Revenue Recognition and other standards were adopted from the beginning of the first quarter of the current fiscal year.」

    Sales expansion through magazine advertising and other measures continued, and sales volume of the large-size and Double Support types exceeded the previous year. However, net sales were below the same quarter of the previous year due to the adoption of the accounting standard for revenue recognition.
  16. FY2021AdvancedAnnual report

    「We actively promoted Oligo no Okage, a food for specified health uses, through various advertising campaigns and other measures and worked to expand sales in order to raise awareness further. As a result, sales remained strong not only for the regular type but also for the large-size and Double Support types, which offer greater functionality, and net sales exceeded the same period of the previous year.」

    In addition to outreach through various advertising campaigns, sales of the large-size and Double Support types were strong, and net sales exceeded the same period of the previous year.
  17. FY2021-Q3AdvancedAnnual report

    「In response to heightened consumer health awareness during the COVID-19 pandemic, the oligosaccharide segment actively used various advertising campaigns and other measures to promote Oligo no Okage, a food for specified health uses, and expand the business further. As a result, sales remained strong not only for the regular type but also for the large-size and Double Support types, which offer greater functionality, and net sales exceeded the same quarter of the previous year.」

    Through proposals using various advertising campaigns and other measures, we worked to increase Oligo no Okage’s market share and expand the business, and net sales exceeded the same quarter of the previous year, including sales of the large-size and Double Support types.
  18. FY2021-Q2AdvancedAnnual report

    「In the oligosaccharide segment, as products that support intestinal health attracted attention during the COVID-19 pandemic and consumers again recognized that improving the intestinal environment can also help maintain immunity, we implemented measures including various advertising campaigns and sales promotions at major mass retailers to expand sales of Oligo no Okage, a food for specified health uses. As a result, sales of the product remained strong not only for the regular type but also for the Double Support type, and net sales exceeded the same quarter of the previous year.」

    In addition to various advertising campaigns and sales promotions at major mass retailers, sales of the Double Support type were strong, and net sales for the oligosaccharide segment exceeded the same quarter of the previous year.
  19. FY2021-Q1AdvancedAnnual report

    「In the oligosaccharide segment, we actively advertised in various magazines to expand sales of Oligo no Okage, a food for specified health uses, as a measure to help prevent infection with the novel coronavirus by improving the intestinal environment and thereby helping maintain and enhance immunity. Amid growing consumer health awareness, we again highlighted the relationship between Oligo no Okage and immunity. As a result, net sales for the oligosaccharide segment as a whole exceeded the same quarter of the previous year.」

    Against the backdrop of heightened health awareness during the novel coronavirus pandemic, magazine advertising and promotion of the relationship with immunity were conducted, and net sales for the oligosaccharide segment exceeded the same quarter of the previous year.
  20. FY202025th-anniversary campaign and expanded promotions amid lower net sales and profitAnnual report

    「The Oligo no Okage product, our flagship product, marked its 25th anniversary. The oligosaccharide segment worked to expand sales by conducting consumer campaigns in partnership with major mass retailers and broadly rolling out in-store sampling campaigns. We also actively advertised and conducted public relations activities using television, magazines, newspapers, and other media to expand operations. However, sales of products for commercial use were weak due to the impact of various external factors, and the oligosaccharide segment as a whole posted lower net sales and profit.」

    Taking the 25th anniversary of the launch of Oligo no Okage as an opportunity, tie-ups with mass retailers, sampling campaigns, and advertising through television, magazines, and newspapers were rolled out, but full-year net sales and profit declined due to weak sales of products for commercial use.
  21. FY2020-Q3Continued sales promotions, lower net sales and profitAnnual report

    「In the oligosaccharide segment, we conducted sales promotions focused on consumers through a broad range of measures, including advertising in magazines and commercials, mannequin-led sampling sales at major mass retailers, and various campaigns, to expand sales of the Oligo no Okage series, one of our flagship products. However, the segment as a whole posted lower net sales and profit.」

    Advertising in magazines and commercials, mannequin-led sampling sales at mass retailers, and various campaigns were rolled out, but the oligosaccharide segment posted lower net sales and profit.
  22. FY2020-Q2Expanded sales promotions, lower net sales but higher profitAnnual report

    「In the oligosaccharide segment, we conducted more direct sales promotion activities targeting consumers through the active use of various media, the broad rollout of sampling campaigns, and measures such as must-buy campaigns to expand sales of the Oligo no Okage series, one of our flagship products. As a result, the oligosaccharide segment as a whole posted lower net sales but higher profit.」

    Promotional methods were expanded to include various media, the broad rollout of sampling campaigns, and must-buy campaigns, but the segment as a whole posted lower net sales and higher profit.
  23. FY2020-Q1Declining sales volume and net salesAnnual report

    「In the oligosaccharide segment, we worked to inform consumers about the advantages of Oligo no Okage over competing products and the functionality of its active ingredients through advertising in magazines and newspapers and participation in and sponsorship of various events. As a result, some products maintained performance at or above the previous year’s level, but both sales volume and net sales for the oligosaccharide segment as a whole were below the same period of the previous year.」

    Consumer outreach through magazine and newspaper advertising and participation in and sponsorship of events was conducted, but sales volume and net sales for the oligosaccharide segment as a whole were below the same period of the previous year.
  24. FY2019AdvancedAnnual report

    「We worked to reach consumers through various media, including television commercials and newspaper advertising, as well as by enhancing our website. At the same time, we continued sales promotions at major mass retailers, including the broad rollout of sampling campaigns. As a result, both sales volume and net sales for the oligosaccharide segment as a whole exceeded the same period of the previous year.」

    Various media, the website, and the broad rollout of sampling campaigns were continued, and sales volume and net sales exceeded the same period of the previous year for the full year.
  25. FY2019-Q3AdvancedAnnual report

    「In the oligosaccharide segment, we strengthened consumer outreach activities, including television commercials, coordinated magazine promotions, and enhancement of our official website, to expand sales of the Oligo no Okage series, a food for specified health uses with benefits in improving the intestinal environment, by raising brand awareness. We also actively conducted sales promotions focused on major mass retailers, including the broad rollout of special sales and sampling campaigns. As a result, both sales volume and net sales for the oligosaccharide segment as a whole exceeded the same period of the previous year.」

    In addition to conventional media and website outreach, special sales and sampling campaigns were rolled out across a wider area, and both sales volume and net sales exceeded the same period of the previous year.
  26. FY2019-Q2AdvancedAnnual report

    「In the oligosaccharide segment, we focused on sales promotions centered on major mass retailers to expand sales of the Oligo no Okage series, a food for specified health uses with benefits in improving the intestinal environment, while continuing measures such as collaborative sampling sales with other products at retail locations. To raise awareness, we also worked to reach general consumers through various media and enhanced the content of our official website. As a result, both sales volume and net sales for the oligosaccharide segment as a whole exceeded the same period of the previous year.」

    Sales promotions at major mass retailers, collaborative sampling sales with other products, media outreach, and enhancement of the official website were continued, and both sales volume and net sales exceeded the same period of the previous year.
  27. FY2019-Q1Expanded official website, continued decline in net salesAnnual report

    「In the oligosaccharide segment, we strengthened sales promotion activities focused on major sales outlets and mass retailers to expand sales and raise awareness of the Oligo no Okage series, a food for specified health uses with benefits in improving the intestinal environment. We also worked to reach general consumers through various media and enhanced the content of our official website. As a result, some products maintained performance at or above the previous year’s level, but both sales volume and net sales for the oligosaccharide segment as a whole were below the same period of the previous year.」

    While enhancing the content of the official website in addition to conventional in-store promotions and media outreach, sales volume and net sales for the segment as a whole were below the same period of the previous year.
  28. FY2018Expanded promotional channels, declining net salesAnnual report

    「In addition to conducting sales expansion campaigns with major distributors and sales promotions at major mass retailers, we worked to reach general consumers through advertising using television, radio commercials, and other media, event sponsorships, and coordinated magazine promotions. Although some products performed better than in the same period of the previous year, net sales for the oligosaccharide segment as a whole were below the same period of the previous year.」

    While promotional measures for major distributors and mass retailers were expanded to include television and radio commercials, events, and coordinated magazine promotions, the segment as a whole posted lower net sales.
  29. FY2018-Q3Expanded sales promotions, declining net salesAnnual report

    「In the oligosaccharide business, we sought to expand operations by enhancing the value of the Oligo no Okage brand. In addition to actively conducting sales expansion campaigns with major distributors and sales promotions focused on major mass retailers, we worked to strengthen sales through advertising on TV commercials and other media, coordinated magazine promotions, and other consumer outreach activities, but net sales were below the same period of the previous year.」

    Enhanced brand value, sales expansion campaigns with major distributors, sales promotions at major mass retailers, and coordinated TV commercial, media, and magazine promotions were rolled out, while net sales were below the same period of the previous year.
  30. FY2018-Q2Continued sales expansion and declining sales volumesAnnual report

    「In the oligosaccharide business, we worked to make the expansion of sales of the highly regarded Oligo no Okage brand, known for its benefits in improving the intestinal environment, more reliable. In addition to strengthening sales promotion activities at major mass retailers and other outlets, we sponsored events and promoted the brand to general consumers through advertising and various other media, but both sales volume and net sales were below the same period of the previous year.」

    While continuing and expanding sales promotions at major mass retailers, event sponsorships, and promotional activities through advertising and various media, sales volume and net sales were below the same period of the previous year.
  31. FY2018-Q1Changes in sales promotion measures and sluggish sales volumesAnnual report

    「In the oligosaccharide business, the company worked to raise awareness of the digestive benefits of improving the “gut flora” by sponsoring events, appealing to general consumers through various media and strengthening sales promotion activities at major mass retailers and other outlets. However, sales volumes for both the consumer and commercial products of “Oligo no Okage” were somewhat sluggish, and sales fell below the level recorded in the same period of the previous year.」

    While continuing and expanding event sponsorships, media activities and sales promotion at major mass retailers, sales volumes for consumer and commercial products were somewhat sluggish.
  32. FY2017-Q3RestatedAnnual report

    「In the oligosaccharide business, in addition to the effect of features on the “gut flora” covered by various media since the previous fiscal year, efforts to appeal to general consumers through television commercials and other measures and to strengthen sales promotion activities at major mass retailers and other outlets supported strong sales volumes for “Oligo no Okage,” and sales exceeded the level recorded in the same period of the previous year.」

    The company continues to expand sales of oligosaccharide products through television commercials, appeals to general consumers and strengthened sales promotion activities at major mass retailers and other outlets.
  33. FY2017-Q2Expansion of sales promotion measuresAnnual report

    「In addition to the effect of features on the “gut flora” covered by various media since the previous fiscal year, efforts to appeal to general consumers through television commercials and other measures and to strengthen sales promotion activities at major mass retailers and other outlets supported strong sales volumes for “Oligo no Okage,” and sales exceeded the level recorded in the same period of the previous year.」

    In addition to the previous sales promotion aimed at major mass retailers, the company explicitly refers to appealing to general consumers through television commercials, indicating a broader range of sales promotion measures.
  34. FY2017-Q1First statedAnnual report

    「In addition to the effect of features on the “gut flora” covered by various media since the previous fiscal year, efforts to strengthen sales promotion activities at major mass retailers and other outlets supported strong sales volumes for “Oligo no Okage,” and sales exceeded the level recorded in the same period of the previous year.」

    The company is expanding sales of oligosaccharide products by strengthening sales promotion activities at major mass retailers and other outlets.
Moved together

"Debt Guarantees for 太平洋製糖" moved the same way as this thread, in the same document, in 10 of its 36 moves.

1076643★123456
  1. ★This thread
  2. 1Debt Guarantees for 太平洋製糖10×
  3. 2Market Value Fluctuation Risk of Marketable Securities7×
  4. 3Revenue and Profit Growth in the Bio Business6×
  5. 4Decline in Equity-Method Investment Profit6×
  6. 5¥5 Dividend per Common Share4×
  7. 6Profit Improvement Amid Declining Sales in the Sugar Business3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Ensuiko Sugar Refining's next results are scheduled for 2026-11-06. Read the earnings preview It last moved in the Earnings of 2026-08-07: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of sales in the oligosaccharide business | Ensuiko Sugar Refining Co.,Ltd. (2112) | Komori